[AT1 blockers against heart failure. The charm of polypharmacy]

MMW Fortschr Med. 2003 Sep 18;145(38):6.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • News

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiotensin II Type 1 Receptor Blockers*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Survival Rate
  • Tetrazoles / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • candesartan